{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T21:24:40Z","timestamp":1791753880223,"version":"4.3.4"},"reference-count":226,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Liver disease is a major threat to human health and life safety, primarily encompassing hepatitis caused by various factors (viral, alcoholic, fatty and autoimmune hepatitis), cirrhosis and liver cancer. Cytokines are molecules found on cell membranes that mediate the inflammation, immunity and a range of cellular functions, such as cell differentiation, proliferation, metastasis and apoptosis. In general, the delicate balance between pro- and anti-inflammatory effects is maintained by the body\u2019s regulatory mechanisms. Once this balance is disturbed, complex chain reactions can occur, including systemic injury, tumor, multi-organ failure or death, resulting in the release of cytokines. This review mainly focuses on the classification, biological characteristics, pathogenesis, signaling pathways of various cytokines (interleukins, interferons, tumor necrosis factor, colony-stimulating factors, chemokines and growth factors) and their important roles in the occurrence and development of different liver diseases, mediating the immune responses, and further discusses the application prospects of cytokines in the clinical treatments of liver diseases.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1694582","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T06:27:11Z","timestamp":1763360831000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["The pivotal role of cytokines in liver disease pathogenesis and therapeutic potential"],"prefix":"10.3389","volume":"16","author":[{"given":"Li","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuhua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.it.2021.06.001","article-title":"The \u2018Cytokine storm\u2019: molecular mechanisms and therapeutic prospects","volume":"42","author":"Karki","year":"2021","journal-title":"Trends Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-020-0301-1","article-title":"Signaling networks in immunometabolism","volume":"30","author":"Saravia","year":"2020","journal-title":"Cell Res"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00119","article-title":"The immunology of macrophage activation syndrome","volume":"10","author":"Crayne","year":"2019","journal-title":"Front Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-021-00649-0","article-title":"Interplay between interleukin-6 signaling and the vascular endothelium in cytokine storms","volume":"53","author":"Kang","year":"2021","journal-title":"Exp Mol Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019003618","article-title":"The earlier the better: timely mitigation of crs","volume":"134","author":"Rouce","year":"2019","journal-title":"Blood"},{"key":"B6","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41577-021-00547-6","article-title":"Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy","volume":"22","author":"Morris","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2020.100924","article-title":"An overview of the non-canonical inflammasome","volume":"76","author":"Downs","year":"2020","journal-title":"Mol Aspects Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23084208","article-title":"The role of inflammasomes in glomerulonephritis","volume":"23","author":"Anton-Pampols","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/2549763","article-title":"Inflammation and inflammasomes: pros and cons in tumorigenesis","volume":"2020","author":"Balahura","year":"2020","journal-title":"J Immunol Res"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24076426","article-title":"The role of cytokines in cholesterol accumulation in cells and atherosclerosis progression","volume":"24","author":"Markin","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1128358","article-title":"Uncoupled pyroptosis and il-1\u03b2 Secretion downstream of inflammasome signaling","volume":"14","author":"Li Y","year":"2023","journal-title":"Front Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3390\/biom12071005","article-title":"Activation and pharmacological regulation of inflammasomes","volume":"12","author":"Chen","year":"2022","journal-title":"Biomolecules"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2020.04.002","article-title":"The interplay among mirnas, major cytokines, and cancer-related inflammation","volume":"20","author":"Chakraborty","year":"2020","journal-title":"Mol Ther - Nucleic Acids"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.21147\/j.issn.1000-9604.2018.06.01","article-title":"Liver cancer incidence and mortality in China: temporal trends and projections to 2030","volume":"30","author":"Zheng","year":"2018","journal-title":"Chin J Cancer Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djab079","article-title":"The mortality and overall survival trends of primary liver cancer in the United States","volume":"113","author":"Lee","year":"2021","journal-title":"JNCI: J Natl Cancer Institute"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.xinn.2020.100032","article-title":"Therapy of primary liver cancer","volume":"1","author":"Feng","year":"2020","journal-title":"Innovation"},{"key":"B17","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/hep.31288","article-title":"Epidemiology of hepatocellular carcinoma","volume":"73","author":"McGlynn","year":"2020","journal-title":"Hepatology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3350\/cmh.2023.0125","article-title":"Recent advances in the management of hepatocellular carcinoma","volume":"30","author":"Sankar","year":"2023","journal-title":"Clin Mol Hepatol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2022.100479","article-title":"Lipid alterations in chronic liver disease and liver cancer","volume":"4","author":"Paul","year":"2022","journal-title":"JHEP Rep"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-022-01890-8","article-title":"Immune Therapies against Chronic hepatitis B","volume":"57","author":"Akbar","year":"2022","journal-title":"J Gastroenterol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1349867","article-title":"The novel mechanism facilitating chronic hepatitis B infection: immunometabolism and epigenetic modification reprogramming","volume":"15","author":"Wang","year":"2024","journal-title":"Front Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m2200","article-title":"Hepatitis B virus persistence and reactivation","volume":"370","author":"Shi","year":"2020","journal-title":"Bmj"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.2147\/jir.S411492","article-title":"Antigen recognition and immune response to acute and chronic hepatitis B virus infection","volume":"16","author":"Adugna","year":"2023","journal-title":"J Inflammation Res"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3390\/cells8111356","article-title":"Natural sulfur-containing compounds: an alternative therapeutic strategy against liver fibrosis","volume":"8","author":"Milito","year":"2019","journal-title":"Cells"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.30582","article-title":"Hepatic stellate cells in the injured liver: perspectives beyond hepatic fibrosis","volume":"237","author":"Ezhilarasan","year":"2021","journal-title":"J Cell Physiol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-020-0230-3","article-title":"Reactive oxygen species (Ros) as pleiotropic physiological signalling agents","volume":"21","author":"Sies","year":"2020","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-022-00910-2","article-title":"Tnf in the liver: targeting a central player in inflammation","volume":"44","author":"Tiegs","year":"2022","journal-title":"Semin Immunopathol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3390\/cells8111419","article-title":"Tgf-B in hepatic stellate cell activation and liver fibrogenesis\u2014Updated 2019","volume":"8","author":"Dewidar","year":"2019","journal-title":"Cells"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01155","article-title":"The interleukin-20 cytokine family in liver disease","volume":"9","author":"Caparr\u00f3s","year":"2018","journal-title":"Front Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s13679-023-00519-y","article-title":"The role of tumor necrosis factor-alpha in the pathogenesis and treatment of nonalcoholic fatty liver disease","volume":"12","author":"Vachliotis","year":"2023","journal-title":"Curr Obes Rep"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.2147\/dddt.S308578","article-title":"Clinical application of cytokines in cancer immunotherapy","volume":"15","author":"Qiu","year":"2021","journal-title":"Drug Design Dev Ther"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00658-5","article-title":"Inflammation and tumor progression: signaling pathways and targeted intervention","volume":"6","author":"Zhao","year":"2021","journal-title":"Signal Transduction Targeted Ther"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-021-00588-9","article-title":"Harnessing cytokines and chemokines for cancer therapy","volume":"19","author":"Propper","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.jaci.2016.06.033","article-title":"Interleukins (from il-1 to il-38), interferons, transforming growth factor B, and tnf-A: receptors, functions, and roles in diseases","volume":"138","author":"Akdis","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.15296","article-title":"Role of interleukin-15 in cardiovascular diseases","volume":"24","author":"Guo","year":"2020","journal-title":"J Cell Mol Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21176009","article-title":"Roles of il-1 in cancer: from tumor progression to resistance to targeted therapies","volume":"21","author":"Gelfo","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.19935","article-title":"The role of interleukin-36 in health and disease states","volume":"38","author":"Sugiura","year":"2024","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.811025","article-title":"The role of il-37 and il-38 in colorectal cancer","volume":"9","author":"Dang","year":"2022","journal-title":"Front Med"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3390\/cells12232766","article-title":"Potential role of il-37 in atopic dermatitis","volume":"12","author":"Mesjasz","year":"2023","journal-title":"Cells"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2018.8","article-title":"Targeting the il-6\/jak\/stat3 signalling axis in cancer","volume":"15","author":"Johnson","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1097\/MPA.0000000000000335","article-title":"Characterization of patients with advanced pancreatic cancer and high serum interleukin-6 levels","volume":"44","author":"Miura","year":"2015","journal-title":"Pancreas"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-007310","article-title":"Increased interleukin-6\/C-reactive protein levels are associated with the upregulation of the adenosine pathway and serve as potential markers of therapeutic resistance to immune checkpoint inhibitor-based therapies in non-small cell lung cancer","volume":"11","author":"Naqash","year":"2023","journal-title":"J ImmunoTherapy Cancer"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2019.03.020","article-title":"Il-10 family cytokines il-10 and il-22: from basic science to clinical translation","volume":"50","author":"Ouyang","year":"2019","journal-title":"Immunity"},{"key":"B44","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jaci.2013.04.035","article-title":"T cell\u2013derived microvesicles induce mast cell production of il-24: relevance to inflammatory skin diseases","volume":"133","author":"Shefler","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjid.2021.101594","article-title":"Pathogenesis of htlv-1 infection and progression biomarkers: an overview","volume":"25","author":"Brites","year":"2021","journal-title":"Braz J Infect Dis"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-023-00768-1","article-title":"Il-12 and il-23 pathway inhibition in inflammatory bowel disease","volume":"20","author":"Verstockt","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2019.03.011","article-title":"The immunobiology of the interleukin-12 family: room for discovery","volume":"50","author":"Tait Wojno","year":"2019","journal-title":"Immunity"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00969","article-title":"Il-27, il-30, and il-35: A cytokine triumvirate in cancer","volume":"9","author":"Kourko","year":"2019","journal-title":"Front Oncol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2022.08.004","article-title":"Harnessing il-15 signaling to potentiate nk cell-mediated cancer immunotherapy","volume":"43","author":"Ma","year":"2022","journal-title":"Trends Immunol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2019.01.013","article-title":"Clinical significance and immunobiology of il-21 in autoimmunity","volume":"99","author":"Long","year":"2019","journal-title":"J Autoimmun"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107692","article-title":"Interleukin-8: A chemokine at the intersection of cancer plasticity, angiogenesis, and immune suppression","volume":"219","author":"Fousek","year":"2021","journal-title":"Pharmacol Ther"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1111\/exd.14036","article-title":"Clinical, microbiological, immunological and imaging characteristics of tunnels and fistulas in hidradenitis suppurativa and crohn\u2019s disease","volume":"29","author":"J\u00f8rgensen","year":"2019","journal-title":"Exp Dermatol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2019.03.012","article-title":"Interleukin-1 and related cytokines in the regulation of inflammation and immunity","volume":"50","author":"Mantovani","year":"2019","journal-title":"Immunity"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06816-9","article-title":"Dictionary of immune responses to cytokines at single-cell resolution","volume":"625","author":"Cui","year":"2023","journal-title":"Nature"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01412","article-title":"Structural basis of il-1 family cytokine signaling","volume":"10","author":"Fields","year":"2019","journal-title":"Front Immunol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/imm.13462","article-title":"The roles of interleukin-1 receptor accessory protein in certain inflammatory conditions","volume":"166","author":"Zarezadeh Mehrabadi","year":"2022","journal-title":"Immunology"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.4110\/in.2024.24.e21","article-title":"Il-1 receptor dynamics in immune cells: orchestrating immune precision and balance","volume":"24","author":"Kim","year":"2024","journal-title":"Immune Network"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.779100","article-title":"Molecular basis of selective cytokine signaling inhibition by antibodies targeting a shared receptor","volume":"12","author":"Fields","year":"2021","journal-title":"Front Immunol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.21037\/tlcr.2018.03.15","article-title":"Can we use interleukin-1\u03b2 Blockade for lung cancer treatment","volume":"7","author":"Gottschlich","year":"2018","journal-title":"Trans Lung Cancer Res"},{"key":"B60","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/imr.12621","article-title":"Overview of the il-1 family in innate inflammation and acquired immunity","volume":"281","author":"Dinarello","year":"2017","journal-title":"Immunol Rev"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(17)32247-x","article-title":"Effect of interleukin-1\u03b2 Inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial","volume":"390","author":"Ridker","year":"2017","journal-title":"Lancet"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2021.04.011","article-title":"Interleukin-1 in tumor progression, therapy, and prevention","volume":"39","author":"Garlanda","year":"2021","journal-title":"Cancer Cell"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.07.041","article-title":"Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis","volume":"74","author":"Gaul","year":"2021","journal-title":"J Hepatol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.4062\/biomolther.2023.232","article-title":"Interleukin-1\u03b2 Signaling contributes to cell cycle arrest and apoptotic cell death by leptin via modulation of akt and P38mapk in hepatocytes","volume":"32","author":"Baral","year":"2024","journal-title":"Biomolecules Ther"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathmechdis-032521-102529","article-title":"Role of the inflammasome in liver disease","volume":"17","author":"de Carvalho Ribeiro","year":"2022","journal-title":"Annu Rev Pathology: Mech Dis"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2020.1761203","article-title":"Different roles of interleukin 6 and interleukin 11 in the liver: implications for therapy","volume":"16","author":"Widjaja","year":"2020","journal-title":"Hum Vaccin Immunother"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-041818-011649","article-title":"Hiding in plain sight: interleukin-11 emerges as a master regulator of fibrosis, tissue integrity, and stromal inflammation","volume":"71","author":"Cook","year":"2020","journal-title":"Annu Rev Med"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-022-00797-1","article-title":"Il-1 and autoinflammatory disease: biology, pathogenesis and therapeutic targeting","volume":"18","author":"Broderick","year":"2022","journal-title":"Nat Rev Rheumatol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/807976","article-title":"Role of il-38 and its related cytokines in inflammation","volume":"2015","author":"Yuan","year":"2015","journal-title":"Mediators Inflammation"},{"key":"B70","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s12016-021-08885-y","article-title":"Defects of the innate immune system and related immune deficiencies","volume":"63","author":"Akar-Ghibril","year":"2021","journal-title":"Clin Rev Allergy Immunol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1276512","article-title":"Tolerogenic dendritic cells and tlr4\/irak4\/nf-Kb signaling pathway in allergic rhinitis","volume":"14","author":"Kang","year":"2023","journal-title":"Front Immunol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.fsi.2016.12.019","article-title":"Cloning and functional characterization of irak4 in large yellow croaker (Larimichthys crocea) that associates with myd88 but impairs nf-Kb activation","volume":"63","author":"Zou","year":"2017","journal-title":"Fish Shellfish Immunol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-016-5098-7","article-title":"Role of interleukin-6 in cancer progression and therapeutic resistance","volume":"37","author":"Kumari","year":"2016","journal-title":"Tumor Biol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2015.10.041","article-title":"Microrna let-7i regulates dendritic cells maturation targeting interleukin-10 via the janus kinase 1\u2013signal transducer and activator of transcription 3 signal pathway subsequently induces prolonged cardiac allograft survival in rats","volume":"35","author":"Sun","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01620-3","article-title":"The il-17 family in diseases: from bench to bedside","volume":"8","author":"Huangfu","year":"2023","journal-title":"Signal Transduction Targeted Ther"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11051328","article-title":"The interleukine-17 cytokine family: role in development and progression of spondyloarthritis, current and potential therapeutic inhibitors","volume":"11","author":"Davydova","year":"2023","journal-title":"Biomedicines"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3390\/cimb46080496","article-title":"Cardiovascular risk in philadelphia-negative myeloproliferative neoplasms: mechanisms and implications\u2014a narrative review","volume":"46","author":"Todor","year":"2024","journal-title":"Curr Issues Mol Biol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"e12776","DOI":"10.1111\/cpr.12776","article-title":"Il-6 promotes metastasis of non-small-cell lung cancer by up-regulating tim-4 via nf-kappab","volume":"53","author":"Liu","year":"2020","journal-title":"Cell Prolif"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.7150\/jca.40656","article-title":"Interleukin 17a promotes gallbladder cancer invasiveness via erk\/nf-kappab signal pathway mediated epithelial-to-mesenchymal transition","volume":"11","author":"Chen","year":"2020","journal-title":"J Cancer"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1111\/all.14526","article-title":"Role of il-25, il-33, and tslp in triggering united airway diseases toward type 2 inflammation","volume":"75","author":"Hong","year":"2020","journal-title":"Allergy"},{"key":"B81","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1089\/jir.2018.0044","article-title":"Interleukin-33 and st2 signaling in tumor microenvironment","volume":"39","author":"Hong","year":"2019","journal-title":"J Interferon Cytokine Res"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04782-4","article-title":"Role of il-33-st2 pathway in regulating inflammation: current evidence and future perspectives","volume":"21","author":"Zhou","year":"2023","journal-title":"J Trans Med"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1418549112","article-title":"T-bet\u2013 and stat4\u2013dependent il-33 receptor expression directly promotes antiviral th1 cell responses","volume":"112","author":"Baumann","year":"2015","journal-title":"Proc Natl Acad Sci"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241512133","article-title":"Novel matrix metalloproteinase-9 (Mmp-9) inhibitors in cancer treatment","volume":"24","author":"Rashid","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-019-09812-6","article-title":"Functional disparities within the timp family in cancer: hints from molecular divergence","volume":"38","author":"Eckfeld","year":"2019","journal-title":"Cancer Metastasis Rev"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20061257","article-title":"Il-36, il-37, and il-38 cytokines in skin and joint inflammation: A comprehensive review of their therapeutic potential","volume":"20","author":"Boutet","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1038\/s41374-021-00544-2","article-title":"Il-37b\u03b41\u201345 suppresses the migration and invasion of endometrial cancer cells by targeting the rac1\/nf-Kb\/mmp2 signal pathway","volume":"101","author":"Wang","year":"2021","journal-title":"Lab Invest"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1007\/s12551-020-00726-0","article-title":"Il-34, il-36 and il-38 in colorectal cancer\u2014Key immunoregulators of carcinogenesis","volume":"12","author":"Bao","year":"2020","journal-title":"Biophys Rev"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1051787","article-title":"The role of il-38 in intestinal diseases - its potential as a therapeutic target","volume":"13","author":"Wang","year":"2022","journal-title":"Front Immunol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-019-0300-7","article-title":"Anti-inflammatory mechanisms of the novel cytokine interleukin-38 in allergic asthma","volume":"17","author":"Sun","year":"2019","journal-title":"Cell Mol Immunol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41423-020-00580-w","article-title":"Immunopathobiology and therapeutic targets related to cytokines in liver diseases","volume":"18","author":"He","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.28337","article-title":"Serum interleukin-6 associated with hepatocellular carcinoma risk: A nested case\u2013control study","volume":"134","author":"Ohishi","year":"2013","journal-title":"Int J Cancer"},{"key":"B93","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","article-title":"A global view of hepatocellular carcinoma: trends, risk, prevention and management","volume":"16","author":"Yang","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1053\/j.gastro.2018.08.065","article-title":"Epidemiology and management of hepatocellular carcinoma","volume":"156","author":"Kulik","year":"2019","journal-title":"Gastroenterology"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.3390\/v14050986","article-title":"Hepatitis B virus-associated hepatocellular carcinoma","volume":"14","author":"Rizzo","year":"2022","journal-title":"Viruses"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00776-0","article-title":"Restoration of hbv-specific cd8+ T-cell responses by sequential low-dose il-2 treatment in non-responder patients after ifn-A Therapy","volume":"6","author":"Wang","year":"2021","journal-title":"Signal Transduction Targeted Ther"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1097\/hep.0000000000000458","article-title":"Future directions in acute liver failure","volume":"78","author":"Stravitz","year":"2023","journal-title":"Hepatology"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0184084","article-title":"Interleukin-1\u03b1 and interleukin-1\u03b2 Play a central role in the pathogenesis of fulminant hepatic failure in mice","volume":"12","author":"Avila","year":"2017","journal-title":"PloS One"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1097\/ccm.0000000000001402","article-title":"Interleukin-1 receptor blockade is associated with reduced mortality in sepsis patients with features of macrophage activation syndrome","volume":"44","author":"Shakoory","year":"2016","journal-title":"Crit Care Med"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2016.62","article-title":"Interleukin-33 in the pathogenesis of liver fibrosis: alarming ilc2 and hepatic stellate cells","volume":"14","author":"Weiskirchen","year":"2016","journal-title":"Cell Mol Immunol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.13990","article-title":"Plasma levels of soluble st2, but not il-33, correlate with the severity of alcoholic liver disease","volume":"23","author":"Sun","year":"2018","journal-title":"J Cell Mol Med"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1281121","article-title":"The role of il-36 and 37 in hepatocellular carcinoma","volume":"15","author":"Cao","year":"2024","journal-title":"Front Immunol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.7150\/jca.47106","article-title":"Il36 indicating good prognosis in human hepatocellular carcinoma","volume":"11","author":"Hu","year":"2020","journal-title":"J Cancer"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02014","article-title":"Interleukin-1 family cytokines: keystones in liver inflammatory diseases","volume":"10","author":"Barbier","year":"2019","journal-title":"Front Immunol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.3390\/v15051215","article-title":"Autoantibodies to interferons in infectious diseases","volume":"15","author":"Quiros-Roldan","year":"2023","journal-title":"Viruses"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.3390\/biom12111554","article-title":"Interferon signaling in the endometrium and in endometriosis","volume":"12","author":"Park","year":"2022","journal-title":"Biomolecules"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2022.175051","article-title":"Type-I interferons in the immunopathogenesis and treatment of coronavirus disease 2019","volume":"927","author":"Khorramdelazad","year":"2022","journal-title":"Eur J Pharmacol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.764062","article-title":"Type iii interferons: emerging roles in autoimmunity","volume":"12","author":"Manivasagam","year":"2021","journal-title":"Front Immunol"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20190295","article-title":"Type iii interferons: balancing tissue tolerance and resistance to pathogen invasion","volume":"217","author":"Broggi","year":"2020","journal-title":"J Exp Med"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.608645","article-title":"Importance of type I and iii interferons at respiratory and intestinal barrier surfaces","volume":"11","author":"Stanifer","year":"2020","journal-title":"Front Immunol"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2018.08.013","article-title":"The role of ifn in the development of nafld and nash","volume":"124","author":"M\u00f8hlenberg","year":"2019","journal-title":"Cytokine"},{"key":"B112","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1038\/cdd.2017.31","article-title":"Retracted article : interactions between th1 cells and tregs affect regulation of hepatic fibrosis in biliary atresia through the ifn-\u0393\/stat1 pathway","volume":"24","author":"Wen","year":"2017","journal-title":"Cell Death Differentiation"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2009.09.002","article-title":"Cross-regulation of signaling pathways by interferon-\u0393: implications for immune responses and autoimmune diseases","volume":"31","author":"Hu","year":"2009","journal-title":"Immunity"},{"key":"B114","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/imr.13092","article-title":"Unique aspects of ifn-\u0393\/stat1 signaling in neurons","volume":"311","author":"Clark","year":"2022","journal-title":"Immunol Rev"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01250-1","article-title":"Comprehensive elaboration of the cgas-sting signaling axis in cancer development and immunotherapy","volume":"19","author":"Zheng","year":"2020","journal-title":"Mol Cancer"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01247-w","article-title":"Cgas-sting pathway in cancer biotherapy","volume":"19","author":"Wang","year":"2020","journal-title":"Mol Cancer"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-020-00916-z","article-title":"Cgas-sting, an important pathway in cancer immunotherapy","volume":"13","author":"Jiang","year":"2020","journal-title":"J Hematol Oncol"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202001607R","article-title":"The cgas-sting pathway: the role of self-DNA sensing in inflammatory lung disease","volume":"34","author":"Ma","year":"2020","journal-title":"FASEB J"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.02.026","article-title":"Interferon-induced il-10 drives systemic T-cell dysfunction during chronic liver injury","volume":"79","author":"Hackstein","year":"2023","journal-title":"J Hepatol"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1631\/jzus.B2300159","article-title":"Key role of interferon regulatory factor 1 (Irf-1) in regulating liver disease: progress and outlook","volume":"25","author":"Chen","year":"2024","journal-title":"J Zhejiang University-SCIENCE B"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-020-02586-9","article-title":"Interferon regulatory factor 1 (Irf-1) and irf-2 regulate pd-L1 expression in hepatocellular carcinoma (Hcc) cells","volume":"69","author":"Yan","year":"2020","journal-title":"Cancer Immunology Immunotherapy"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-021-01803-1","article-title":"Sting and liver disease","volume":"56","author":"Chen","year":"2021","journal-title":"J Gastroenterol"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1038\/312724a0","article-title":"Human tumour necrosis factor_ precursor structure, expression and homology to lymphotoxin","volume":"312","author":"Pennica D","year":"1984","journal-title":"Nature"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(90)90815-v","article-title":"Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor","volume":"61","author":"Loetscher H","year":"1990","journal-title":"Cell"},{"key":"B125","article-title":"Action of bacterial polysaccharide on tumors. Iii. Repeated response of sarcoma 37, in tolerant mice, to serratia marcescens endotoxin","volume":"23","author":"O'Malley","year":"1963","journal-title":"Cancer Res"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.903679","article-title":"Tumor necrosis factor A: taking a personalized road in cancer therapy","volume":"13","author":"Ben-Baruch","year":"2022","journal-title":"Front Immunol"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2023.103575","article-title":"Small-molecule modulators of tumor necrosis factor signaling","volume":"28","author":"Ch\u00e9dotal","year":"2023","journal-title":"Drug Discov Today"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19935-y","article-title":"Ubiquitination of ripk1 regulates its activation mediated by tnfr1 and tlrs signaling in distinct manners","volume":"11","author":"Li","year":"2020","journal-title":"Nat Commun"},{"key":"B129","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/ncb2883","article-title":"Plasma membrane translocation of trimerized mlkl protein is required for tnf-induced necroptosis","volume":"16","author":"Cai","year":"2013","journal-title":"Nat Cell Biol"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.2147\/ott.S241344","article-title":"Tumor necrosis factor alpha-induced proteins in Malignant tumors: progress and prospects","volume":"13","author":"Guo","year":"2020","journal-title":"OncoTargets Ther"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24043735","article-title":"Alcohol, inflammation, and microbiota in alcoholic liver disease","volume":"24","author":"Duki\u0107","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.29628","article-title":"Gene expression of tumor necrosis factor [Alpha ] and tnf-receptors, P55 and P75, in nonalcoholic steatohepatitis patients","volume":"34","author":"Crespo","year":"2001","journal-title":"Hepatology"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2017.3015","article-title":"Therapeutic strategies for alcoholic liver disease: focusing on inflammation and fibrosis (Review)","volume":"40","author":"Kawaratani","year":"2017","journal-title":"Int J Mol Med"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.15631","article-title":"Circulating tumor necrosis factor-A Levels in non-alcoholic fatty liver disease: A systematic review and a meta-analysis","volume":"36","author":"Potoupni","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-024-01042-5","article-title":"Tumor necrosis factor-inducible gene 6 protein and its derived peptide ameliorate liver fibrosis by repressing cd44 activation in mice with alcohol-related liver disease","volume":"31","author":"Han","year":"2024","journal-title":"J Biomed Sci"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2023.05.017","article-title":"Sublethal necroptosis signaling promotes inflammation and liver cancer","volume":"56","author":"Vucur","year":"2023","journal-title":"Immunity"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-025-01310-w","article-title":"Nf-Kb in inflammation and cancer","volume":"22","author":"Mao","year":"2025","journal-title":"Cell Mol Immunol"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1097\/hep.0000000000001070","article-title":"Haf prevents hepatocyte apoptosis and progression to mash and hcc through transcriptional regulation of the nf-Kb pathway","volume":"82","author":"Acu\u00f1a-Pilarte","year":"2025","journal-title":"Hepatology"},{"key":"B139","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1055\/s-0038-1676806","article-title":"Inflammation and liver cancer: molecular mechanisms and therapeutic targets","volume":"39","author":"Yang","year":"2019","journal-title":"Semin Liver Dis"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2022.06.001","article-title":"Easl clinical practice guidelines on the management of hepatic encephalopathy","volume":"77","author":"Montagnese","year":"2022","journal-title":"J Hepatol"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.09.004","article-title":"Corrigendum to \u201cEasl clinical practice guidelines on the management of hepatic encephalopathy\u201d","volume":"79","author":"Montagnese","year":"2023","journal-title":"J Hepatol"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.Mct-20-0591","article-title":"Csf1\/csf1r signaling inhibitor pexidartinib (Plx3397) reprograms tumor-associated macrophages and stimulates T-cell infiltration in the sarcoma microenvironment","volume":"20","author":"Fujiwara","year":"2021","journal-title":"Mol Cancer Ther"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013532.pub2","article-title":"Granulocyte colony-stimulating factor with or without stem or progenitor cell or growth factors infusion for people with compensated or decompensated advanced chronic liver disease","volume":"2023","author":"Colli","year":"2023","journal-title":"Cochrane Database Systematic Rev"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-318419","article-title":"Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-pd-L1 blockade","volume":"68","author":"Zhu","year":"2019","journal-title":"Gut"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00379","article-title":"Chemokines and chemokine receptors: new targets for cancer immunotherapy","volume":"10","author":"Mollica Poeta","year":"2019","journal-title":"Front Immunol"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21218412","article-title":"Cc chemokines in a tumor: A review of pro-cancer and anti-cancer properties of the ligands of receptors ccr1, ccr2, ccr3, and ccr4","volume":"21","author":"Korbecki","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B147","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/imr.12746","article-title":"Chemokines and other mediators in the development and functional organization of lymph nodes","volume":"289","author":"Eckert","year":"2019","journal-title":"Immunol Rev"},{"key":"B148","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.canlet.2020.03.018","article-title":"The chemokine ccl7 regulates invadopodia maturation and mmp-9 mediated collagen degradation in liver-metastatic carcinoma cells","volume":"483","author":"Qi","year":"2020","journal-title":"Cancer Lett"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-80689-0","article-title":"Lect2 as a hepatokine links liver steatosis to inflammation via activating tissue macrophages in nash","volume":"11","author":"Takata","year":"2021","journal-title":"Sci Rep"},{"key":"B150","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ctrv.2017.08.004","article-title":"Interleukin-8 in cancer pathogenesis, treatment and follow-up","volume":"60","author":"Alfaro","year":"2017","journal-title":"Cancer Treat Rev"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.4066","article-title":"Cxcr1\/2 antagonism with cxcl8 interleukin-8 analogue cxcl8(3\u201372)K11r G31p restricts lung cancer growth by inhibiting tumor cell proliferation and suppressing angiogenesis","volume":"6","author":"Khan","year":"2015","journal-title":"Oncotarget"},{"key":"B152","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.canlet.2019.04.002","article-title":"Cancer-associated fibroblasts-derived il-8 mediates resistance to cisplatin in human gastric cancer","volume":"454","author":"Zhai","year":"2019","journal-title":"Cancer Lett"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01355-1","article-title":"Targeting cxcr2 inhibits the progression of lung cancer and promotes therapeutic effect of cisplatin","volume":"20","author":"Cheng","year":"2021","journal-title":"Mol Cancer"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-316324","article-title":"Tumour-associated macrophages-derived cxcl8 determines immune evasion through autonomous pd-L1 expression in gastric cancer","volume":"68","author":"Lin","year":"2019","journal-title":"Gut"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01337-3","article-title":"Pmn-mdscs modulated by ccl20 from cancer cells promoted breast cancer cell stemness through cxcl2-cxcr2 pathway","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduction Targeted Ther"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1111\/cas.12603","article-title":"Overexpression of chemokine receptor cxcr2 and ligand cxcl7 in liver metastases from colon cancer is correlated to shorter disease-free and overall survival","volume":"106","author":"Desurmont","year":"2015","journal-title":"Cancer Sci"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30140","article-title":"Lect2 controls inflammatory monocytes to constrain the growth and progression of hepatocellular carcinoma","volume":"69","author":"L\u2019Hermitte","year":"2018","journal-title":"Hepatology"},{"key":"B158","article-title":"Ccr10_Ccl27 crosstalk regulates cell metastasis via pi3k-akt signaling axis in non-small-cell lung cancer","volume":"13","author":"Liu","year":"2021","journal-title":"Am J Transl Res"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22189804","article-title":"Chemokine-directed tumor microenvironment modulation in cancer immunotherapy","volume":"22","author":"Bule","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021011557","article-title":"The age of the bone marrow microenvironment influences B-cell acute lymphoblastic leukemia progression via cxcr5-cxcl13","volume":"138","author":"Zanetti","year":"2021","journal-title":"Blood"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22105170","article-title":"Alcohol-related liver disease: basic mechanisms and clinical perspectives","volume":"22","author":"Liu","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B162","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41575-022-00688-6","article-title":"Global epidemiology of alcohol-associated cirrhosis and hcc: trends, projections and risk factors","volume":"20","author":"Huang","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04166-8","article-title":"Pathogenic mechanisms and regulatory factors involved in alcoholic liver disease","volume":"21","author":"Yan","year":"2023","journal-title":"J Trans Med"},{"key":"B164","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41572-018-0014-7","article-title":"Alcoholic liver disease","volume":"4","author":"Seitz","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1172\/jci176345","article-title":"Alcohol-associated liver disease","volume":"134","author":"Mackowiak","year":"2024","journal-title":"J Clin Invest"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2021.100346","article-title":"New targets for nafld","volume":"3","author":"Parlati","year":"2021","journal-title":"JHEP Rep"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1604480","article-title":"Macrophages in nonalcoholic fatty liver disease: A role model of pathogenic immunometabolism","volume":"37","author":"Krenkel","year":"2017","journal-title":"Semin Liver Dis"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1097\/hep.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (Nafld) and nonalcoholic steatohepatitis (Nash): A systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2029349","article-title":"Prospective study of outcomes in adults with nonalcoholic fatty liver disease","volume":"385","author":"Sanyal","year":"2021","journal-title":"New Engl J Med"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30249","article-title":"Pharmacological inhibition of ccr2\/5 signaling prevents and reverses alcohol-induced liver damage, steatosis, and inflammation in mice","volume":"69","author":"Ambade","year":"2019","journal-title":"Hepatology"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30036","article-title":"Hepatocellular carcinoma is associated with gut microbiota profile and inflammation in nonalcoholic fatty liver disease","volume":"69","author":"Ponziani","year":"2018","journal-title":"Hepatology"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202154446","article-title":"Nlrp3 activation in neutrophils induces lethal autoinflammation, liver inflammation, and fibrosis","volume":"23","author":"Kaufmann","year":"2022","journal-title":"EMBO Rep"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.03.038","article-title":"An integrated view of anti-inflammatory and antifibrotic targets for the treatment of nash","volume":"79","author":"Tacke","year":"2023","journal-title":"J Hepatol"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22073490","article-title":"The role of cxcl16 in the pathogenesis of cancer and other diseases","volume":"22","author":"Korbecki","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31617","article-title":"Endothelial P300 promotes portal hypertension and hepatic fibrosis through C-C motif chemokine ligand 2\u2013mediated angiocrine signaling","volume":"73","author":"Gao","year":"2021","journal-title":"Hepatology"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.83530","article-title":"C-C motif chemokine receptor 2 inhibition reduces liver fibrosis by restoring the immune cell landscape","volume":"19","author":"Guo","year":"2023","journal-title":"Int J Biol Sci"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23126696","article-title":"Combined therapy with a ccr2\/ccr5 antagonist and fgf21 analogue synergizes in ameliorating steatohepatitis and fibrosis","volume":"23","author":"Puengel","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03233-8","article-title":"Auto-aggressive cxcr6+ Cd8 T cells cause liver immune pathology in nash","volume":"592","author":"Dudek","year":"2021","journal-title":"Nature"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02159","article-title":"The role of cxc chemokine receptors 1\u20134 on immune cells in the tumor microenvironment","volume":"9","author":"Susek","year":"2018","journal-title":"Front Immunol"},{"key":"B182","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1053\/j.gastro.2015.05.058","article-title":"Interleukin-8 induces expression of foxc1 to promote transactivation of cxcr1 and ccl2 in hepatocellular carcinoma cell lines and formation of metastases in mice","volume":"149","author":"Huang","year":"2015","journal-title":"Gastroenterology"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21155186","article-title":"The ccl20-ccr6 axis in cancer progression","volume":"21","author":"Kadomoto","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.02.036","article-title":"Fgf19\/fgfr4-mediated elevation of etv4 facilitates hepatocellular carcinoma metastasis by upregulating pd-L1 and ccl2","volume":"79","author":"Xie","year":"2023","journal-title":"J Hepatol"},{"key":"B185","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3892\/or.2017.6069","article-title":"Ccl2\/ccr2 axis induces hepatocellular carcinoma:Invasion and epithelial-mesenchymal transition in vitro:through activation of the hedgehog pathway","volume":"39","author":"Zhuang","year":"2018","journal-title":"Oncol Rep"},{"key":"B186","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/sciadv.1600188","article-title":"Material-driven fibronectin assembly for high-efficiency presentation of growth factors","volume":"2","author":"Llopis-Hern\u00e1ndez","year":"2016","journal-title":"Sci Adv"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-biochem-050410-100030","article-title":"Structure and regulation of soluble guanylate cyclase","volume":"81","author":"Derbyshire","year":"2012","journal-title":"Annu Rev Biochem"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2115774119","article-title":"No rapidly mobilizes cellular heme to trigger assembly of its own receptor","volume":"119","author":"Dai","year":"2022","journal-title":"Proc Natl Acad Sci"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00077.2014","article-title":"Dynamic alterations in hippo signaling pathway and yap activation during liver regeneration","volume":"307","author":"Grijalva","year":"2014","journal-title":"Am J Physiology-Gastrointestinal Liver Physiol"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.12118","article-title":"Defective initiation of liver regeneration in osteopontin-deficient mice after partial hepatectomy due to insufficient activation of il-6\/stat3 pathway","volume":"11","author":"Wen","year":"2015","journal-title":"Int J Biol Sci"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.108683","article-title":"Signaling pathways of liver regeneration: biological mechanisms and implications","volume":"27","author":"Zhang","year":"2024","journal-title":"iScience"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.14110","article-title":"Notch signaling pathway regulates cell cycle in proliferating hepatocytes involved in liver regeneration","volume":"33","author":"Zhang","year":"2018","journal-title":"J Gastroenterol Hepatol"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-023-01335-9","article-title":"Bipotent transitional liver progenitor cells contribute to liver regeneration","volume":"55","author":"Pu","year":"2023","journal-title":"Nat Genet"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222011217","article-title":"Progranulin a promotes compensatory hepatocyte proliferation via hgf\/C-met signaling after partial hepatectomy in zebrafish","volume":"22","author":"Chiang","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B195","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ejphar.2017.10.044","article-title":"Schisandrol B promotes liver regeneration after partial hepatectomy in mice","volume":"818","author":"Li","year":"2018","journal-title":"Eur J Pharmacol"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2023.106657","article-title":"Astaxanthin: A promising therapeutic agent for organ fibrosis","volume":"188","author":"Li","year":"2023","journal-title":"Pharmacol Res"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2020.4491","article-title":"Panax notoginseng saponins prevent senescence and:Inhibit apoptosis by regulating the pi3k\u2212Akt\u2212Mtor:Pathway in osteoarthritic chondrocytes","volume":"45","author":"Zhang","year":"2020","journal-title":"Int J OF Mol Med"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2010.04.053","article-title":"Toward delivery of multiple growth factors in tissue engineering","volume":"31","author":"Chen","year":"2010","journal-title":"Biomaterials"},{"key":"B199","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms22020903","article-title":"Advances in growth factor delivery for bone tissue engineering","volume":"22","author":"Oliveira","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1003376","article-title":"The role of gut microbiota in liver regeneration","volume":"13","author":"Xu","year":"2022","journal-title":"Front Immunol"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms11030597","article-title":"The gut\u2013liver axis in pediatric liver health and disease","volume":"11","author":"Rager","year":"2023","journal-title":"Microorganisms"},{"key":"B202","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.cytogfr.2016.11.004","article-title":"Post-transcriptional regulation of cytokine and growth factor signaling in cancer","volume":"33","author":"Vlasova-St. Louis","year":"2017","journal-title":"Cytokine Growth Factor Rev"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21218414","article-title":"Liver regeneration after hepatectomy and partial liver transplantation","volume":"21","author":"Yagi","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcdb.2017.07.041","article-title":"Mechanosensing in liver regeneration","volume":"71","author":"Song","year":"2017","journal-title":"Semin Cell Dev Biol"},{"key":"B205","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1038\/s41467-024-44760-y","article-title":"Identification of myeloid-derived growth factor as a mechanically-induced, growth-promoting angiocrine signal for human hepatocytes","volume":"15","author":"Gro\u00dfe-Segerath","year":"2024","journal-title":"Nat Commun"},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-051116-052415","article-title":"Immune responses in the liver","volume":"36","author":"Kubes","year":"2018","journal-title":"Annu Rev Immunol"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1038\/nature13989","article-title":"Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors","volume":"518","author":"Gomez Perdiguero","year":"2014","journal-title":"Nature"},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24021176","article-title":"Liver regeneration and immunity: A tale to tell","volume":"24","author":"Di-Iacovo","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.3390\/biom14040476","article-title":"Innate immunity and masld","volume":"14","author":"Meyer","year":"2024","journal-title":"Biomolecules"},{"key":"B210","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2020.1681397","article-title":"A role for il-1 inhibitors in the treatment of non-alcoholic fatty liver disease (Nafld)","volume":"29","author":"Tilg","year":"2019","journal-title":"Expert Opin Investigational Drugs"},{"key":"B211","doi-asserted-by":"publisher","DOI":"10.3390\/diseases12040069","article-title":"The role of cytokines in the pathogenesis and treatment of alcoholic liver disease","volume":"12","author":"Scarlata","year":"2024","journal-title":"Diseases"},{"key":"B212","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.Cir-18-0622","article-title":"Antibody\u2013cytokine fusions: versatile products for the modulation of anticancer immunity","volume":"7","author":"Neri","year":"2019","journal-title":"Cancer Immunol Res"},{"key":"B213","doi-asserted-by":"publisher","first-page":"e2002214","DOI":"10.1002\/adhm.202002214","article-title":"Engineered cytokines for cancer and autoimmune disease immunotherapy","volume":"10","author":"Uricoli","year":"2021","journal-title":"Adv Healthc Mater"},{"key":"B214","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.cbpa.2021.01.007","article-title":"Cytokine engineering for targeted cancer immunotherapy","volume":"62","author":"Bonati","year":"2021","journal-title":"Curr Opin Chem Biol"},{"key":"B215","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41573-022-00557-6","article-title":"Emerging principles of cytokine pharmacology and therapeutics","volume":"22","author":"Saxton","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"B216","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s41423-021-00786-6","article-title":"The use of supercytokines, immunocytokines, engager cytokines, and other synthetic cytokines in immunotherapy","volume":"19","author":"Zheng","year":"2022","journal-title":"Cell Mol Immunol"},{"key":"B217","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/s44222-023-00030-y","article-title":"Engineering cytokine therapeutics","volume":"1","author":"Deckers","year":"2023","journal-title":"Nat Rev Bioengineering"},{"key":"B218","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22980-w","article-title":"A cytokine receptor-masked il2 prodrug selectively activates tumor-infiltrating lymphocytes for potent antitumor therapy","volume":"12","author":"Hsu","year":"2021","journal-title":"Nat Commun"},{"key":"B219","doi-asserted-by":"publisher","DOI":"10.1038\/s41551-022-00888-0","article-title":"Masking the immunotoxicity of interleukin-12 by fusing it with a domain of its receptor via a tumour-protease-cleavable linker","volume":"6","author":"Mansurov","year":"2022","journal-title":"Nat Biomed Eng"},{"key":"B220","doi-asserted-by":"publisher","DOI":"10.1097\/cm9.0000000000002759","article-title":"Advances in immunotherapy for biliary tract cancers","volume":"137","author":"Zhao","year":"2023","journal-title":"Chin Med J"},{"key":"B221","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2022.03.014","article-title":"Combined therapy with ivermectin and doxycycline can effectively alleviate the cytokine storm of covid-19 infection amid vaccination drive: A narrative review","volume":"15","author":"Sharma","year":"2022","journal-title":"J Infection Public Health"},{"key":"B222","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1380313","article-title":"The combination therapy of oncolytic virotherapy","volume":"15","author":"Wang","year":"2024","journal-title":"Front Pharmacol"},{"key":"B223","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22115801","article-title":"Tumor immune microenvironment and immunosuppressive therapy in hepatocellular carcinoma: A review","volume":"22","author":"Oura","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B224","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a021535","article-title":"Treatment of liver cancer","volume":"5","author":"Liu","year":"2015","journal-title":"Cold Spring Harbor Perspect Med"},{"key":"B225","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2021.01.036","article-title":"Maintaining manganese in tumor to activate cgas-sting pathway evokes a robust abscopal anti-tumor effect","volume":"331","author":"Wang","year":"2021","journal-title":"J Controlled Release"},{"key":"B226","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.765101","article-title":"Immunotherapy for hepatocellular carcinoma: current status and future prospects","volume":"12","author":"Liu","year":"2021","journal-title":"Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1694582\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T06:27:12Z","timestamp":1763360832000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1694582\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,17]]},"references-count":226,"alternative-id":["10.3389\/fimmu.2025.1694582"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1694582","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,17]]},"article-number":"1694582"}}